Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Samuel Lunenfeld Research Institute, Mount Sinai Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Canada register with Samuel Lunenfeld Research Institute, Mount Sinai Hospital as lead sponsor. Synced 19 Nov 2026
18Current trials
13Recruiting now
9Drugs in these trials
1Trial register
At a glance

Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 18 current clinical trials in our Canada register. 13 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Oxytocin, Carbetocin and Ephedrine. The most-studied condition is Postpartum Hemorrhage.

ClinicalTrials.gov trials by status

  • Recruiting1372%
  • Not yet open317%
  • Active, closed211%

Trials by phase

  • Not applicable1583%
  • Observational317%
01

Clinical trials sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital

18 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Oxytocin Maintenance Infusion in Labouring Women Undergoing Cesarean Delivery: an Up-down Sequential Allocation Study
NCT05290129 · ClinicalTrials.gov ↗ · Postpartum Hemorrhage
Drug: Oxytocin
Not applicable Recruiting 2022-08 Canada
Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium
NCT06930391 · ClinicalTrials.gov ↗ · Postpartum Hemorrhage (Primary)
Not applicable Recruiting 2025-09 Canada
A Digital Educational Resource to Improve Preparedness for Shared Decision Making About Labour Analgesia
NCT07516171 · ClinicalTrials.gov ↗ · Labour Analgesia
Not applicable Recruiting 2026-07 Canada
Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium
NCT06285409 · ClinicalTrials.gov ↗ · Postpartum Hemorrhage
Not applicable Recruiting 2024-04 Canada
Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women (PART II)
NCT06655675 · ClinicalTrials.gov ↗ · Labor Pain
Not applicable Recruiting 2024-10 Canada
Modified Deep Extubation vs. Standard Awake Extubation
NCT06318715 · ClinicalTrials.gov ↗ · Extubation
Not applicable Recruiting 2024-04 Canada
Quality of Labour Epidural Analgesia With Intrathecal Morphine as a Component of Combined Spinal Epidural
NCT06572241 · ClinicalTrials.gov ↗ · Labor Pain
Drug: Morphine
Not applicable Recruiting 2024-11 Canada
Patient Experiences of Intraoperative Discomfort During Cesarean Delivery Under Neuraxial Anesthesia
NCT07867106 · ClinicalTrials.gov ↗ · Discomfort, Psychological Well Being
Observational Recruiting 2026-10 Canada
Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study
NCT04053478 · ClinicalTrials.gov ↗ · Hypotension
Not applicable Recruiting 2019-07 Canada
Aspiration Risk Assessment by Gastric Ultrasound in eMErgency Surgery and ANesThetic Decision-making: The ARGUMENT Study
NCT06303492 · ClinicalTrials.gov ↗ · Pulmonary Aspiration, Emergency Surgery
Not applicable Recruiting 2024-06 Canada
Hyperangulated vs. Macintosh Style Blades for Intubation in Obstetric Patients
NCT07667010 · ClinicalTrials.gov ↗ · Obstetric, Cesarean Birth, Airway Anesthesia
Not applicable Recruiting 2026-06 Canada
Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery
NCT07187544 · ClinicalTrials.gov ↗ · Postpartum Hemorrhage (Primary)
Not applicable Recruiting 2025-12 Canada
Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery
NCT06333340 · ClinicalTrials.gov ↗ · Post Partum Hemorrhage
Not applicable Recruiting 2025-01 Canada
Post-operative Cognitive Decline After Ambulatory Cataract Surgery in the Elderly Population
NCT07714174 · ClinicalTrials.gov ↗ · Post-Operative Cognitive Decline in Older Adults, Post-operative Cognitive Decline, Perioperative Neurocognitive Disorders
Observational Not yet open 2026-08 Canada
Title of Study: Anesthesiologists' Learning Curves for Ultrasound Assessment of Difficult Airway
NCT07910071 · ClinicalTrials.gov ↗ · Airway Ultrasound, Difficult Airway Management, Airway Ultrasonography
Not applicable Not yet open 2026-11 Canada
ASIGN Trial- Angulated Versus Standard Video-laryngoscope Blade in Nasal Intubation
NCT07822308 · ClinicalTrials.gov ↗ · Nasal Intubation
Not applicable Not yet open 2026-10 Canada
Association of Body Fluid Distribution With Obstructive Sleep Apnea in Pregnant Women With Body Mass Index ≥ 40 kg/m2
NCT04187612 · ClinicalTrials.gov ↗ · Apnea, Obstructive Sleep, Obesity
Observational Active, closed 2019-12 Canada
Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study
NCT06285396 · ClinicalTrials.gov ↗ · Postpartum Hemorrhage
Not applicable Active, closed 2024-03 Canada

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Samuel Lunenfeld Research Institute, Mount Sinai Hospital trials

9 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Samuel Lunenfeld Research Institute, Mount Sinai Hospital trials

26 conditions
Postpartum Hemorrhage3Postpartum Hemorrhage (Primary)2Labor Pain2Post-Operative Cognitive Decline in Older Adults1Post-operative Cognitive Decline1Perioperative Neurocognitive Disorders1Cataract Surgery Anesthesia1Labour Analgesia1Airway Ultrasound1Difficult Airway Management1Airway Ultrasonography1Medical Education1Apnea, Obstructive Sleep1Obesity1Nasal Intubation1Extubation1Discomfort1Psychological Well Being1Hypotension1Pulmonary Aspiration1Emergency Surgery1Obstetric1Cesarean Birth1Airway Anesthesia1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Canada1813

A trial with sites in more than one country appears in each of those registers.

05

Questions about Samuel Lunenfeld Research Institute, Mount Sinai Hospital trials

How many clinical trials does Samuel Lunenfeld Research Institute, Mount Sinai Hospital sponsor?

Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 18 current trials on ClinicalTrials.gov in our Canada register, as of the registry sync on 19 November 2026. Completed and withdrawn studies are not counted.

Are Samuel Lunenfeld Research Institute, Mount Sinai Hospital trials recruiting?

Yes. 13 of its 18 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Samuel Lunenfeld Research Institute, Mount Sinai Hospital testing?

Its current trials name 9 drugs and biologicals as interventions. The most frequent are Oxytocin (5), Carbetocin (4), Ephedrine (2), Norepinephrine (2) and Phenylephrine (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.